Snapshot from Sep 17, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory securities class action

PROCEPT BioRobotics Securities Fraud Class Action

Analysis based on 303 articles · First reported Jul 24, 2026 · Last updated Aug 31, 2026

Sentiment
-60
Attention
4
Articles
303
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The securities fraud allegations and subsequent stock drops have significantly eroded investor confidence in PROCEPT BioRobotics, leading to a cumulative decline of over 48% in share price. The class action lawsuit and potential settlements could impose substantial financial liabilities on the company, while the elimination of the discount program may reduce future revenue growth.

Medical Devices Healthcare

A securities fraud class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) and certain of its executives, alleging that the company violated federal securities laws by failing to disclose that it used an extensive discount program to incentivize customers to place bulk handpiece orders in excess of procedure demand. This undisclosed program artificially inflated reported U.S. handpiece unit sales and revenues by pulling forward sales from future periods, creating a glut of field inventory exceeding 10,000 units. The class period runs from February 28, 2024 to February 25, 2026. The lead plaintiff deadline is September 22, 2026. The case is pending in the United States — United States District Court for the Northern District of California, captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, No. 26-cv-07691. Multiple law firms, including Kahn Swick & Foti, Hagens Berman, Glancy Prongay Wolke & Rotter, Kaplan Fox, Rosen Law Firm, Pomerantz, Bleichmar Fonti & Auld, Robbins Geller, and others, are soliciting investors to participate. The stock dropped significantly following disclosures: on August 6, 2025, shares fell 16% after Q2 results missed estimates; on November 4, 2025, shares fell over 10% after Q3 results and guidance cut; and on February 25, 2026, shares fell 18% after Q4 results revealed the inventory glut and elimination of the discount program. Overall, the stock declined over 48% from August 2025 to February 2026.

100 Levi & Korsinsky filed securities class action PROCEPT BioRobotics
100 Robbins LLP filed class action PROCEPT BioRobotics
90 Rosen Law Firm filed class action PROCEPT BioRobotics
90 DJS Law Group filed class action PROCEPT BioRobotics
85 PROCEPT BioRobotics suffered stock decline
84 PROCEPT BioRobotics missed sales guidance
83 PROCEPT BioRobotics disclosed excess field inventory
80 Pomerantz LLP filed class action PROCEPT BioRobotics
80 Hagens Berman filed class action PROCEPT BioRobotics
80 Kahn Swick & Foti filed class action PROCEPT BioRobotics
80 Glancy Prongay & Murray filed securities fraud lawsuit PROCEPT BioRobotics
+ 26 more actions View on Dashboard
stock
Central defendant in the securities fraud class action. The company's stock plummeted over 48% from August 2025 to February 2026 due to revelations of undisclosed discounting and inventory glut, and it now faces significant legal and financial exposure.
Importance 100.0 Sentiment -80.0
priv
One of the plaintiff law firms that announced the class action and is soliciting lead plaintiffs. Its role is to represent investors in seeking recovery.
Importance 60.0 Sentiment 0.0
priv
One of the plaintiff law firms soliciting investors for the class action. It benefits from potential fees if the case succeeds.
Importance 60.0 Sentiment 20.0
priv
Plaintiff law firm leading investigation and soliciting investors. It has secured over $2.9 billion in similar cases.
Importance 60.0 Sentiment 20.0
priv
Plaintiff law firm involved in the class action, seeking lead plaintiff role.
Importance 50.0 Sentiment 20.0
priv
Plaintiff law firm involved in the class action, seeking lead plaintiff role.
Importance 50.0 Sentiment 20.0
priv
Plaintiff law firm involved in the class action, seeking lead plaintiff role.
Importance 50.0 Sentiment 20.0
priv
Plaintiff law firm involved in the class action, seeking lead plaintiff role.
Importance 50.0 Sentiment 20.0
priv
Plaintiff law firm involved in the class action, seeking lead plaintiff role.
Importance 50.0 Sentiment 20.0
per
CFO of PROCEPT, named as defendant. He provided guidance that missed estimates and admitted to inventory issues.
Importance 50.0 Sentiment -50.0
priv
Plaintiff law firm involved in the class action, seeking lead plaintiff role.
Importance 40.0 Sentiment 20.0
priv
Plaintiff law firm involved in the class action, seeking lead plaintiff role.
Importance 40.0 Sentiment 20.0
govactor
Court where the class action is pending.
Importance 40.0 Sentiment 0.0
per
Former CEO of PROCEPT, named as defendant. He announced elimination of Chief Commercial Officer role.
Importance 40.0 Sentiment -50.0
per
CEO of PROCEPT, named as defendant. He admitted to not managing customer inventory.
Importance 40.0 Sentiment -50.0
+ 16 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.